Cited by 587PI3K/AKT/mTOR signaling in cancerCancer, Hypoxia, and MetabolismSirtuins and Resveratrol in Medicine

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

Open access

Csibi, Alfred, Fendt, Sarah-Maria, Li, Chenggang, Poulogiannis, George, Choo, Andrew Y., Chapski, Douglas J., Jeong, Seung Min, Dempsey, Jamie M., Parkhitko, Andrey, Morrison, Tasha, Henske, Elizabeth P., Haigis, Marcia C., Cantley, Lewis C., Stephanopoulos, Gregory, Yu, Jane, Blenis, John·2013·Cell

DOI 10.1016/j.cell.2013.04.023PMC PMC3684628

Open this paper in CoChat — free account Open PDF

Abstract

Proliferating mammalian cells use glutamine as a source of nitrogen and as a key anaplerotic source to provide metabolites to the tricarboxylic acid cycle (TCA) for biosynthesis. Recently, mammalian target of rapamycin complex 1 (mTORC1) activation has been correlated with increased nutrient uptake and metabolism, but no molecular connection to glutaminolysis has been reported. Here, we show that mTORC1 promotes glutamine anaplerosis by activating glutamate dehydrogenase (GDH). This regulation requires transcriptional repression of SIRT4, the mitochondrial-localized sirtuin that inhibits GDH. Mechanistically, mTORC1 represses SIRT4 by promoting the proteasome-mediated destabilization of cAMP-responsive element binding 2 (CREB2). Thus, a relationship between mTORC1, SIRT4, and cancer is suggested by our findings. Indeed, SIRT4 expression is reduced in human cancer, and its overexpression reduces cell proliferation, transformation, and tumor development. Finally, our data indicate that targeting nutrient metabolism in energy-addicted cancers with high mTORC1 signaling may be an effective therapeutic approach.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2013.04.023

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citation
Cox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L., & Sabatini, D. M. (2008) · Science · doi:10.1126/science.1157535 · Cited by 2,773
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124

Flagged first, then by citations

Show all 59 references

Sorted by citations

Items 101–200 of 587

Sirtuins, metabolism, and DNA repair
Choi, J.-E., & Mostoslavsky, R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.05.005 · Cited by 136
Caloric restriction and cancer: molecular mechanisms and clinical implications
Meynet, O., & Ricci, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.05.001 · Cited by 143
Metabolic Reprogramming in Brain Tumors
Venneti, S., & Thompson, C. B. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044329 · Cited by 139
Metabolic reprogramming and its clinical implication for liver cancer
Yang, F., Hilakivi-Clarke, L. A., Shaha, A., Wang, Y., Wang, X., Deng, Y., Lai, J., & Kang, N. (2023) · Hepatology · doi:10.1097/hep.0000000000000005 · Cited by 140
A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle
Wang, B., Pei, J., Xu, S., Liu, J., & Yu, J. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02994-0 · Cited by 140
Self-citation
Hepatocellular carcinoma and lifestyles
Saran, U., Humar, B., Kolly, P., & Dufour, J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.028 · Cited by 126
Glutamate Dehydrogenase, a Complex Enzyme at a Crucial Metabolic Branch Point
Smith, H. Q., Li, C., Stanley, C. A., & Smith, T. J. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2428-0 · Cited by 133
Self-citation
Nuclear mTOR Signaling Orchestrates Transcriptional Programs Underlying Cellular Growth and Metabolism
Zhao, T., Fan, J., Abu‐Zaid, A., Burley, S. K., & Zheng, X. (2024) · Cells · doi:10.3390/cells13090781 · Cited by 133
Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity
Tsai, S., Sitzmann, J. M., Dastidar, S. G., Rodriguez, A. A., Vu, S. L., McDonald, C. E., Academia, E. C., O’Leary, M. N., Ashe, T. D., La Spada, A. R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77361 · Cited by 126
SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma
Jeong, S. M., Lee, A., Lee, J., & Haigis, M. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525949 · Cited by 121
Self-citation
Metabolic reprogramming and the role of mitochondria in polycystic kidney disease
Podrini, C., Cassina, L., & Boletta, A. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109495 · Cited by 124
Non-invasive metabolic imaging of brain tumours in the era of precision medicine
Kim, M. M., Parolia, A., Dunphy, M. P., & Venneti, S. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.108 · Cited by 121
Metabolic Regulation of Redox Balance in Cancer
Purohit, V., Simeone, D. M., & Lyssiotis, C. A. (2019) · Cancers · doi:10.3390/cancers11070955 · Cited by 121
Signaling, metabolism, and cancer: An important relationship for therapeutic intervention
Vaghari‐Tabari, M., Ferns, G. A., Qujeq, D., Andevari, A. N., Sabahi, Z., & Moein, S. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30276 · Cited by 126
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway
Yuan, L., Sheng, X., Willson, A. K., Roque, D. R., Stine, J. E., Guo, H., Jones, H. M., Zhou, C., & Bae-Jump, V. L. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0192 · Cited by 116
Biochemical Genetic Pathways that Modulate Aging in Multiple Species: Figure 1.Preprint
Bitto, A., Wang, A. M., Bennett, C. F., & Kaeberlein, M. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025114 · Cited by 122
The roles of sirtuins family in cell metabolism during tumor development
Zhu, S., Dong, Z., Ke, X., Hou, J., Zhao, E., Zhang, K., Wang, F., Yang, L., Xiang, Z., & Cui, H. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.003 · Cited by 113
A nexus for cellular homeostasis: the interplay between metabolic and signal transduction pathways
Gomes, A. P., & Blenis, J. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.12.007 · Cited by 112
Self-citation
Metabolic responses of CHO cells to limitation of key amino acids
Duarte, T. M., Carinhas, N., Barreiro, L. C., Carrondo, M. J. T., Alves, P. M., & Teixeira, A. P. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25266 · Cited by 110
Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis
Dasgupta, S., Putluri, N., Long, W., Zhang, B., Wang, J., Kaushik, A., Arnold, J. M., Bhowmik, S. K., Stashi, E., Brennan, C. A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76029 · Cited by 112
Milk—A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation
Melnik, B. C. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817048 · Cited by 108
Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers
Okazaki, A., Gameiro, P. A., Christodoulou, D. C., Laviolette, L. A., Schneider, M., Chaves, F. L., Stemmer-Rachamimov, A. O., Yazinski, S. A., Lee, R. E., Jr., Stephanopoulos, G. N., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87800 · Cited by 110
Self-citation
O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1
Zhu, Q., Zhou, H., Wu, L., Lai, Z., Geng, D., Yang, W., Zhang, J., Fan, Z., Qin, W., Wang, Y., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01085-5 · Cited by 107
Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients
Liu, G., Zhu, J., Yu, M., Cai, C., Zhou, Y., Yu, M., Fu, Z., Gong, Y., Yang, B., Li, Y., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0500-6 · Cited by 104
Cellular and molecular effects of the mTOR inhibitor everolimus
Saran, U., Foti, M., & Dufour, J. (2015) · Clinical Science · doi:10.1042/cs20150149 · Cited by 111
Glutamine Addiction In Gliomas
Márquez, J., Alonso, F. J., Matés, J. M., Segura, J. A., Martín‐Rufián, M., & Campos-Sandoval, J. A. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2212-1 · Cited by 106
Sirtuins' control of autophagy and mitophagy in cancer
Aventaggiato, M., Vernucci, E., Barreca, F., Russo, M. A., & Tafani, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107748 · Cited by 103
An RNA–RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity
Wei, Y., Tang, X., Ren, Y., Yang, Y. S., Song, F., Fu, J., Liu, S., Yu, M., Chen, J., Wang, S., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00801-2 · Cited by 102
Metabolic characterization and RNA profiling reveal glycolytic dependence of profibrotic phenotype of alveolar macrophages in lung fibrosis
Xie, N., Cui, H., Ge, J., Banerjee, S., Guo, S., Dubey, S., Abraham, E. H., Liu, R.-M., & Liu, G. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00235.2017 · Cited by 102
Targeting glutamine metabolism slows soft tissue sarcoma growth
Lee, P., Malik, D. M., Perkons, N. R., Huangyang, P., Khare, S., Rhoades, S. D., Gong, Y.-Y., Burrows, M., Finan, J. M., Nissim, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14374-1 · Cited by 105
Mitochondrial Dysfunction and the Aging Immune System
McGuire, P. J. (2019) · Biology · doi:10.3390/biology8020026 · Cited by 103
Molecular mechanisms of mTOR regulation by stress
Heberle, A. M., Prentzell, M. T., van Eunen, K., Bakker, B. M., Grellscheid, S. N., & Thedieck, K. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.970489 · Cited by 102
mTOR and Aging: An Old Fashioned Dress
Stallone, G., Infante, B., Prisciandaro, C., & Grandaliano, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112774 · Cited by 97
Intracellular Mono-ADP-Ribosylation in Signaling and Disease
Bütepage, M., Eckei, L., Verheugd, P., & Lüscher, B. (2015) · Cells · doi:10.3390/cells4040569 · Cited by 94
Regulatory principles in metabolism–then and now
Curi, R., Newsholme, P., Marzuca-Nassr, G. N., Takahashi, H., Hirabara, S. M., Cruzat, V. F., Krause, M. D. S., & de Bittencourt, P. I. H. (2016) · Biochemical Journal · doi:10.1042/bcj20160103 · Cited by 99
Metabolic Plasticity of Tumor Cell Mitochondria
Cannino, G., Ciscato, F., Masgras, I., Sànchez‐Martìn, C., & Rasola, A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00333 · Cited by 97
Glutamine Metabolism in Brain Tumors
Natarajan, S. K., & Venneti, S. (2019) · Cancers · doi:10.3390/cancers11111628 · Cited by 99
Regulation of rDNA transcription in response to growth factors, nutrients and energy
Kusnadi, E. P., Hannan, K. M., Hicks, R. J., Hannan, R. D., Pearson, R. B., & Kang, J. (2014) · Gene · doi:10.1016/j.gene.2014.11.010 · Cited by 105
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Li, X., Peng, X., Li, Y., Wei, S., He, G., Liu, J., Li, X., Yang, S., Dai, L., Lin, W., et al. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01449-x · Cited by 103
Targeting sirtuins for cancer therapy: epigenetics modifications and beyond
Shen, H., Qi, X., Hu, Y., Wang, Y., Zhang, J., Liu, Z., & Qin, Z. (2024) · Theranostics · doi:10.7150/thno.100667 · Cited by 95
Amino acids and autophagy: cross-talk and co-operation to control cellular homeostasis
Carroll, B., Korolchuk, V. I., & Sarkar, S. (2014) · Amino Acids · doi:10.1007/s00726-014-1775-2 · Cited by 99
REPTOR and REPTOR-BP Regulate Organismal Metabolism and Transcription Downstream of TORC1
Tiebe, M., Lutz, M., Garza, A. D. L., Buechling, T., Boutros, M., & Teleman, A. A. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.03.013 · Cited by 95
MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer
Craze, M. L., Cheung, H., Jewa, N., Coimbra, N. D. M., Soria, D., Ansari, R. E., Aleskandarany, M. A., Cheng, K. W., Diez, M., Nolan, C. C., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.387 · Cited by 92
Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors
Lorendeau, D., Rinaldi, G., Boon, R., Spincemaille, P., Metzger, K., Jäger, C., Christen, S., Dong, X., Kuenen, S., Voordeckers, K., et al. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.11.005 · Cited by 95
Self-citation
Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism
Brockmueller, A., Sameri, S., Líšková, A., Zhai, K., Varghese, E., Samuel, S. M., Büsselberg, D., Kubatka, P., & Shakibaei, M. (2021) · Cancers · doi:10.3390/cancers13020188 · Cited by 89
Metabolism leaves its mark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria
Papanicolaou, K. N., O'Rourke, B. P., & Foster, D. B. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00301 · Cited by 85
Who watches the watchmen? Regulation of the expression and activity of sirtuins
Buler, M., Andersson, U., & Hakkola, J. (2016) · The FASEB Journal · doi:10.1096/fj.201600410rr · Cited by 92
Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
Ricci, J., & Chiche, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00556 · Cited by 87
Sirtuins and the Metabolic Hurdles in Cancer
German, N. J., & Haigis, M. C. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.012 · Cited by 84
Self-citation
Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer
Tomaselli, D., Steegborn, C., Mai, A., & Rotili, D. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00474 · Cited by 80
Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance
Lyssiotis, C. A., Son, J., Cantley, L. C., & Kimmelman, A. C. (2013) · Cell Cycle · doi:10.4161/cc.25307 · Cited by 83
Self-citation
Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming
Zwaans, B. M. M., & Lombard, D. B. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016287 · Cited by 81
Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential
George, J., & Ahmad, N. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2733 · Cited by 81
Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies
Zhu, Y., Liu, J., Park, J., Rai, P., & Zhai, R. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.002 · Cited by 82
Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer
Shao, Y., Ye, G., Ren, S., Piao, H., Zhao, X., Lu, X., Wang, F., Ma, W., Li, J. X., Yin, P., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31313 · Cited by 82
Self-citation
Mitochondrial Function, Metabolic Regulation, and Human Disease Viewed through the Prism of Sirtuin 4 (SIRT4) Functions
Betsinger, C. N., & Cristea, I. M. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00086 · Cited by 84
Metabolic Adaptation to Nutritional Stress in Human Colorectal Cancer
Miyo, M., Konno, M., Nishida, N., Sueda, T., Noguchi, K., Matsui, H., Colvin, H. S., Kawamoto, K., Koseki, J., Haraguchi, N., et al. (2016) · Scientific Reports · doi:10.1038/srep38415 · Cited by 77
Canonical signaling and nuclear activity of mTOR —a teamwork effort to regulate metabolism and cell growth
Giguère, V. (2018) · FEBS Journal · doi:10.1111/febs.14384 · Cited by 79
Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine‐Monophosphate–Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice
Wang, Y., Du, L., Liang, X., Meng, P., Bi, L., Wang, Y., Wang, C., & Tang, B. (2018) · Hepatology · doi:10.1002/hep.30421 · Cited by 77
SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis
Zhu, Y., Yan, Y., Principe, D. R., Zou, X., Vassilopoulos, A., & Gius, D. R. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-15 · Cited by 77
Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy forIDH1mutant glioma
Nagashima, H., Tanaka, K., Sasayama, T., Irino, Y., Sato, N., Takeuchi, Y., Kyotani, K., Mukasa, A., Mizukawa, K., Sakata, J., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now090 · Cited by 76
Lymphangioleiomyomatosis: A Monogenic Model of Malignancy
Krymskaya, V. P., & McCormack, F. X. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104245 · Cited by 75
Lkb1 deficiency confers glutamine dependency in polycystic kidney disease
Flowers, E., Sudderth, J., Zacharias, L. G., Mernaugh, G., Zent, R., DeBerardinis, R. J., & Carroll, T. J. (2018) · Nature Communications · doi:10.1038/s41467-018-03036-y · Cited by 77
Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies
Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 74
Sirtuins in Cancer: a Balancing Act between Genome Stability and Metabolism
Jeong, S. M., & Haigis, M. C. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0167 · Cited by 74
Self-citation
Luteolin induces apoptosis in vitro through suppressing the MAPK and PI3K signaling pathways in gastric cancer
Lü, X., Li, Y., Li, X., & Aisa, H. A. (2017) · Oncology Letters · doi:10.3892/ol.2017.6380 · Cited by 76
Glutamine Metabolism Is Essential for Stemness of Bone Marrow Mesenchymal Stem Cells and Bone Homeostasis
Zhou, T., Yang, Y., Chen, Q., & Xie, L. (2019) · Stem Cells International · doi:10.1155/2019/8928934 · Cited by 73
CDK 2 positively regulates aerobic glycolysis by suppressing SIRT 5 in gastric cancer
Tang, Z., Li, L., Tang, Y., Xie, D., Wu, K., Wei, W., & Xiao, Q. (2018) · Cancer Science · doi:10.1111/cas.13691 · Cited by 71
Using mitochondrial sirtuins as drug targets: disease implications and available compounds
Gertz, M., & Steegborn, C. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2180-7 · Cited by 73
Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A
Xu, B.-H., Li, X., Yang, Y., Zhang, M.-Y., Rao, H., Wang, H., & Zheng, X. F. S. (2015) · Oncotarget · doi:10.18632/oncotarget.5175 · Cited by 70
Research progress on Sirtuins (SIRTs) family modulators
Chen, M., Tan, J., Jin, Z., Jiang, T., Wu, J., & Yu, X. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116481 · Cited by 73
Aging Reduces an ERRalpha-Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells
Huang, T., Liu, R., Fu, X., Yao, D., Yang, M., Liu, Q., Lu, W. W., Wu, C., & Guan, M. (2016) · Stem Cells · doi:10.1002/stem.2470 · Cited by 69
Dose‐Dependent Carbon‐Dot‐Induced ROS Promote Uveal Melanoma Cell Tumorigenicity via Activation of mTOR Signaling and Glutamine Metabolism
Ding, Y., Yu, J., Chen, X., Wang, S., Tu, Z., Shen, G., Wang, H., Jia, R., Ge, S., Ruan, J., et al. (2021) · Advanced Science · doi:10.1002/advs.202002404 · Cited by 66
Self-citation
Characterization of Histone Deacetylase Mechanisms in Cancer Development
Hai, R., He, L., Shu, G., & Yin, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700947 · Cited by 69
The sirtuin family in cancer
Costa‐Machado, L. F., & Fernández-Marcos, P. J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1634953 · Cited by 66
SIRT4 and Its Roles in Energy and Redox Metabolism in Health, Disease and During Exercise
Han, Y., Zhou, S., Coetzee, S., & Chen, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01006 · Cited by 72
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
Yin, X., Peng, J., Gu, L., Liu, Y., Li, X., Wu, J., Xu, B., Zhuge, Y., & Zhang, F. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05409-0 · Cited by 75
Hepatitis C virus infection triggers a tumor‐like glutamine metabolism
Levy, P. L., Duponchel, S., Eischeid, H., Molle, J., Michelet, M., Diserens, G., Vermathen, M., Vermathen, P., Dufour, J., Dienes, H., et al. (2016) · Hepatology · doi:10.1002/hep.28949 · Cited by 71
The pleiotropic effects of the glutamate dehydrogenase (GDH) pathway in Saccharomyces cerevisiae
Mara, P., Fragiadakis, G. S., Gkountromichos, F., & Alexandraki, D. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-1018-4 · Cited by 65
LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancerPreprint
Xu, P., Oosterveer, M. H., Stein, S. M. A., Demagny, H., Ryu, D., Moullan, N., Wang, X., Can, E., Zamboni, N., Comment, A., et al. (2016) · Genes & Development · doi:10.1101/gad.277483.116 · Cited by 65
Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway
Li, J., Zhan, H., Ren, Y., Feng, M., Wang, Q., Jiao, Q., Wang, Y., Liu, X., Zhang, S., Du, L., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01063-3 · Cited by 63
Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators
Xu, H. M., Liu, Y., Li, L.-S., & Liu, Y. (2023) · Aging and Disease · doi:10.14336/ad.2022.1123 · Cited by 69
Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer
Zacharias, N. M., McCullough, C., Shanmugavelandy, S. S., Lee, J.-H., Lee, Y., Dutta, P., McHenry, J., Nguyen, L., Norton, W., Jones, L. W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16327-z · Cited by 67
Glutamine Metabolism in Osteoprogenitors Is Required for Bone Mass Accrual and PTH-Induced Bone Anabolism in Male Mice
Stegen, S., Devignes, C.-S., Torrekens, S., Looveren, R. V., Carmeliet, P., & Carmeliet, G. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4219 · Cited by 67
Targeting metabolism in breast cancer: How far we can go?
Long, J. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.122 · Cited by 65
p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis
Lam, H. C., Baglini, C. V., Lope, A. L., Parkhitko, A. A., Liu, H.-J., Alesi, N., Malinowska, I. A., Ebrahimi‐Fakhari, D., Saffari, A., Yu, J. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2458 · Cited by 63
Self-citation
Autophagy and cancer cell metabolism
Anderson, C. M., & Macleod, K. F. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.06.002 · Cited by 63
CtBP maintains cancer cell growth and metabolic homeostasis via regulating SIRT4
Wang, L., Zhou, H., Wang, Y., Cui, G., & Di, L.-J. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.587 · Cited by 62
Geroncogenesis: Metabolic Changes during Aging as a Driver of Tumorigenesis
Wu, L. E., Gomes, A. P., & Sinclair, D. A. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.005 · Cited by 62
Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways
van Geldermalsen, M., Quek, L., Turner, N. A., Freidman, N., Pang, A., Guan, Y. F., Krycer, J. R., Ryan, R. M., Wang, Q., & Holst, J. (2018) · BMC Cancer · doi:10.1186/s12885-018-4599-8 · Cited by 62
SIRT4 regulates cancer cell survival and growth after stress
Jeong, S. M., Hwang, S., & Seong, R. H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.078 · Cited by 61
Self-citation
De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition
Tarrado‐Castellarnau, M., de Atauri, P., Tarragó‐Celada, J., Perarnau, J., Yuneva, M. O., Thomson, T. M., & Cascante, M. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167321 · Cited by 60
Revisiting Histone Deacetylases in Human Tumorigenesis: The Paradigm of Urothelial Bladder Cancer
Giannopoulou, A. F., Velentzas, A. D., Konstantakou, E. G., Avgeris, M., Katarachia, S. A., Papandreou, N. C., Kalavros, N., Mpakou, V., Iconomidou, V. A., Anastasiadou, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061291 · Cited by 62
Nitric oxide and tumor metabolic reprogramming
Lopez-Sanchez, L. M., Aranda, E., & Rodríguez‐Ariza, A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113769 · Cited by 63
Overview of Cancer Metabolism and Signaling Transduction
Chae, H., & Hong, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010012 · Cited by 66
The importance of mitochondrial folate enzymes in human colorectal cancer
Miyo, M., Konno, M., Colvin, H. S., Nishida, N., Koseki, J., Kawamoto, K., Tsunekuni, K., Nishimura, J., Hata, T., Takemasa, I., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.5264 · Cited by 60
Abnormal mTORC1 signaling leads to retinal pigment epithelium degeneration
Huang, J., Gu, S., Chen, M., Zhang, S., Jiang, Z., Chen, X., Jiang, C., Liu, G., Radu, R. A., Sun, X., et al. (2019) · Theranostics · doi:10.7150/thno.26281 · Cited by 63
Metabolic and mind shifts
Corbet, C., & Féron, O. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000178 · Cited by 61
Natural Products as Modulators of Sirtuins
Karaman, B., Sippl, W., & Ntie‐Kang, F. (2020) · Molecules · doi:10.3390/molecules25143287 · Cited by 60
Molecular and cellular regulatory roles of sirtuin protein
Pande, S., & Raisuddin, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2070722 · Cited by 58

Authors: Csibi, A., Fendt, S.-M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., Henske, E. P., Haigis, M. C., Cantley, L. C., Stephanopoulos, G., Yu, J., & Blenis, J.
Affiliations: Harvard University (US)
Massachusetts Institute of Technology (US)
Brigham and Women's Hospital (US)
Corresponding author: Blenis, John
ORCID: Fendt, Sarah-Maria
Li, Chenggang
Poulogiannis, George
Chapski, Douglas J.
Jeong, Seung Min
Parkhitko, Andrey
Morrison, Tasha
Henske, Elizabeth P.
Haigis, Marcia C.
Cantley, Lewis C.
Stephanopoulos, Gregory
Yu, Jane
Blenis, John
Venue: Cell
Publisher: Elsevier BV
Published: 2013-05
Volume: 153
Issue: 4
Pages: 840-854
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2013.04.023
PMC: PMC3684628
OpenAlex: W2033228549
Cited by: 586
References: 59
Citations by year: 2026: 16 · 2025: 23 · 2024: 52 · 2023: 37 · 2022: 47 · 2021: 42 · 2020: 49 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 55 · 2015: 56 · 2014: 52 · 2013: 13
FWCI: 26.30
Type: journal article
Language: en
Update notices: erratum (2021-04-15)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 373 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Lirias (KU Leuven) (submittedVersion, other-oa)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Funders: Glenn Foundation for Medical Research
Pfizer
University of Pennsylvania
Johns Hopkins University
Life Sciences Research Foundation
National Research Foundation
Deutsche Forschungsgemeinschaft
Fondation pour la Recherche Médicale
National Research Foundation of Korea
National Institutes of Health
National Institute on Aging (R01AG032375, AG032375)
National Heart, Lung, and Blood Institute (R01HL098216, R01HL121266, HL098216)
National Cancer Institute (R01CA160458)
National Institute of General Medical Sciences (GM51405, R01GM051405)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords: mTORC1, SIRT4, glutamine metabolism, glutamine anaplerosis, glutamate dehydrogenase, ATF4, proteasomal degradation, cell proliferation, cancer metabolism, nutrient metabolism, tumor suppression, TCA cycle
MeSH terms: Mechanistic Target of Rapamycin Complex 1, Tuberous Sclerosis Complex 2 Protein, Animals, Embryo, Mammalian, Energy Metabolism, Glutamate Dehydrogenase, Glutamine, Humans, Neoplasm Transplantation, Neoplasms, Transcription, Genetic, Transplantation, Heterologous, Mitochondrial Proteins, Tumor Suppressor Proteins, Sirtuins, Multiprotein Complexes, Cell Proliferation, Mice, Activating Transcription Factors, Ubiquitination, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks